Three acetylcholinesterase inhibitors used in mild to moderate Alzheimer’s
donepezil
galantamine
rivastigmine
MOA of memantine
NMDA receptor antagonist
NICE recommend memantine for:
MMSE score - mild impairment
20 - 24
MMSE score - moderate impairment
13 - 20
MMSE score - severe impairement
<12
Lewy Body dementia, core clinical features
fluctuating cognition
visual hallucinations
parkinsonism
Pharmacological management of Lewy Body dementia
AChE inhibitors or memantine